Key facts
- Johnson & Johnson will not enter the obesity market.
- The company will focus on diseases such as cancer.
- This decision comes amid significant growth in the obesity market.
Johnson & Johnson has decided against entering the burgeoning obesity market, a sector currently experiencing substantial growth. Instead, the company plans to direct its resources and focus towards developing treatments for diseases like cancer.